GCGR and metabolic dysfunction-associated steatohepatitis: We identified ALT-801 (previously known as SP-1373, Spitfire Pharma, Inc.), as a potent, long-acting, and evenly balanced agonist of the GLP-1R and GCGR that was optimized for NASH and weight loss20,21.